Jiangsu pharmaceutical enterprises four giants dominate the market of 10 billion! Exclusive review injection stakes with FeifeiZijiang.

Howson's two products a day are approved! Take the first imitation, 4 billion large varieties of the next city on June 22, Hansen Pharmaceuticals issued a continuous announcement that the company's subsidiary Jiangsu Hausson Pharmaceuticals developed the Paliquinone slow release tablets and Au nitrogen flat collapse tablets were approved, both products are to copy 4 categories of declaration, approved after the same through the consistency evaluation, which, Paliquinone relief tablets are the first domestic imitation.
Henson Pharmaceuticals said the approval of the two products will further enrich and improve the group's central nervous system product line layout.
in recent years, China's public medical institutions terminal paliquinone tablet sales (units: 10,000 yuan) Paliquinone slow release tablets for atypical antipsychotic drugs, suitable for the treatment of adults and 12-17 years of age adolescents (weight of 29 kg) schizophrenia. according to data from
- and mione.com, sales of paliketone tablets at the end of Public Medical Institutions in China in 2019 amounted to 315 million yuan, with only imported raw research products listed for sale.
days ago, Jiangsu Haussen Pharmaceuticals' Paliquinone slow release tablets to copy the 4 categories of declaration was approved, one shot won the first imitation of the first review.
in addition, the Paliquinone slow release tablets of Oyi Pharmaceuticals, a stone pharmaceutical group, are also listed as generic 4 categories, in the review and approval (at the drug review center).
in recent years, China's public medical institutions terminal O nitrogen flat tablet sales (units: 10,000 yuan) at present, the domestic market sales of Au Nitrogen Ping including Au nitrogen tablets and Au nitrogen flat collapse tablets. according to
-meter net data, in 2019 China's public medical institutions terminal sales of more than 4 billion yuan, Jiangsu Hausen Pharmaceuticals market share ranked first, up to 63.9 percent.
before this, only Lilly and Qilu Pharmaceuticals, Hebei Longhai Pharmaceuticals, Guangdong East Sunshine Pharmaceuticals, Jiangsu Hausen Pharmaceuticals have been approved.
Jiangsu pharmaceutical enterprises four giants dominate the market of 10 billion! 15 products have been evaluated, injections only 1 in recent years China's public medical institutions terminal chemical psychostable drug sales (units: 10,000 yuan) It is worth noting that the recent Yangzijiang hydrochloric acid Lulasiketone tablets and Shijiazhuang four drugs of hydrochloric acid right metoric injections were copied 4 Class, imitation 3 category submitted to the listing application by CDE, Hengrui Pharmaceuticals to the U.S. FDA to declare the right methane sodium chloride injection simple new drug application (ANDA) has been approved, in a series of "actions" behind the psychostable drug market or will be again storm.
-meter-net data show that in 2019, China's public medical institutions terminal chemical psychostabilizer sales exceeded 15 billion yuan, an increase of 9.64 percent year-on-year.
China's public medical institutions terminal chemical drug mental stability drug TOP20 manufacturers sales pattern from top20 manufacturers sales pattern, Hausen Pharmaceuticals, Hengrui Pharmaceuticals, Enhua Pharmaceuticals, Yangzijiang four Jiangsu enterprises ranked in the top four, the total market share of more than 40%.
, YangZijiang with the exclusive evaluation of hydrochloric acid right-metomidin injection into the top four.
data show that in June 2018, Yangzijiang hydrochloric acid right-metomidin injection was approved for listing with 3 types of imitation, and treated as a review, followed by the exclusive winning bid "4 plus 7" collection, alliance area collection, 2018 market share of less than 1%, in 2019, a surge of more than 180 times, market share of 32.94%, second only to Hengrui Pharmaceutical.
2019 China's public medical institutions terminal chemical drug psychostabilizer products TOP10 (units: billion yuan) producttop10, the top three of the O nitrogen flat tablets, hydrochloric acid right-metomidin injection, fumaatin sulfur flat tablet sales are more than 1.5 billion yuan.
as of June 23, 15 products of psychostable drugs through (including the same pass) consistency evaluation, right Zopipic tablets, chlor-nitrogen flat tablets, fumaatine sulfur flat release tablets and other 6 products have 3 or more enterprises have been evaluated.
from the dosage form, the injection only hydrochloric acid right metoric injection 1 overrated.
mental stability drug evaluation situation 29 products in the trial, Enhua, Collum, Huahai ... Or the review tide is reviewing the mental stability drug consistency evaluation and imitation listing declaration at present, is reviewing the mental stability drug consistency evaluation application has 29 products, involving more than 100 acceptance number.
, the most sought-after injections of O nitrogen tablets, hydrochloric acid right-hand Tomidin injections, involving Hengrui Pharmaceuticals, Sichuan Collum Pharmaceuticals, Renfu Pharmaceuticals, Enhua Pharmaceuticals, Huahai Pharmaceuticals, Guangdong East Sunshine Pharmaceuticals and other super 20 enterprises.
Source: State Drug Administration official website, Minnet database, listed company announcement and other original title: Jiangsu pharmaceutical enterprises four giants dominate the market of 10 billion! Exclusive over-rated injections with Feifeizijiang, Howson took the first imitation, stone medicine followed closely.